Pallas Health vs Regenics: Clinician Choice and Pricing
Quick verdict: Pallas Health vs Regenics
Pallas Health vs Regenics: both offer telehealth access to compounded GLP-1s starting at $139 first month, but Pallas includes FDA-approved brand options and clinician-led medication selection while Regenics emphasizes nurse-practitioner oversight and a Sermorelin add-on. Early verdict: choose Pallas for brand-name options and a clinician decision between brand and compounded; choose Regenics for nurse-practitioner led compounded care with a peptide option.
See Pallas Health plans and start intake
How they compare at a glance
| Criteria | Pallas Health | Regenics |
|---|---|---|
| Clinician oversight | US-licensed clinician reviews history and personalizes plan | Licensed nurse practitioners review intake before prescribing |
| Medications offered | FDA-approved Wegovy, Ozempic, Zepbound, Mounjaro and compounded semaglutide/tirzepatide | Compounded semaglutide and tirzepatide plus Sermorelin peptide |
| Starting pricing | Compounded semaglutide $139 first month; compounded tirzepatide $179 first month | Semaglutide $139 first month; tirzepatide $189 first month |
| Renewal/pricing model | Compounded semaglutide renews $597 every 12 weeks (about $199/mo avg); plans priced by medication not mg | Semaglutide renews $199/mo; tirzepatide renews $279/mo per captured FAQ |
| Shipping and pharmacies | Free expedited, compounded in the USA; compounding pharmacies prepare meds | Free shipping, compounded in the USA; pharmacy network LegitScript certified |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
View Regenics compounded options
Distinctive difference 1: Brand-name availability vs compounded focus
Pallas Health documents that US-licensed clinicians can choose between FDA-approved brand-name pens such as Wegovy, Ozempic, Zepbound and Mounjaro or clinician-personalized compounded semaglutide and tirzepatide when a brand medication is not the right fit. Regenics, by contrast, is presented as a compounded-first platform offering semaglutide, tirzepatide and an optional Sermorelin peptide. This makes Pallas the only provider here with explicit brand-name offerings captured in the source.
Distinctive difference 2: Clinician model and scope of care
Pallas emphasizes a US-licensed clinician review and says provider care is included in an all-in plan price with ongoing check-ins and messaging. Regenics specifies licensed nurse practitioners oversee prescriptions and offers a nurse-practitioner-led model with a separate peptide line. Both require a licensed clinician to determine medical appropriateness; the source notes Pallas is clinician-led and Regenics is nurse-practitioner-led.
Distinctive difference 3: Pricing structure and renewal cadence
Pallas lists compounded semaglutide as $139 for the first month with renewals set at $597 every 12 weeks, described as a $199/month average, and notes compounded plans are priced by medication rather than milligram so titration does not raise the plan price. Regenics lists promotional first-month pricing—semaglutide $139 and tirzepatide $189—with renewals at $199/month and $279/month respectively per the captured FAQ. The sources preserve that promotional pricing applies to the first month at Regenics and that Pallas uses a 12 week renewal for compounded plans.
Compare Pallas pricing and meds
Distinctive difference 4: Additional features and certifications
Pallas highlights features like no membership fee, a self-serve portal, refund if a clinician decides treatment is not right, and LegitScript Healthcare Merchant Certification with published medical team disclosures. Regenics highlights a LegitScript-certified pharmacy network, FSA/HSA eligibility, and an offered Sermorelin peptide for recovery, energy and muscle support. Captured evidence shows both rely on US compounding pharmacies and both include the regulatory note that compounded medications are not FDA-approved finished products.
What is not supplied
The captured Regenics landing-page evidence was partially unreadable and some operational details such as cancellation timing or care-team hours beyond what is stated were not supplied in the source. No outcomes, shipping exceptions, or insurance billing beyond the captured cash-pay and FSA/HSA notes are provided in the sources and are therefore not asserted here.
Pallas Health vs Regenics: final guidance
In summary, Pallas Health vs Regenics differs most on brand-name availability, clinician model, pricing cadence and added services. Choose based only on the captured facts below.
- Choose Pallas Health if you want a clinician who can choose between FDA-approved brand pens and compounded preparations, provider care included in an all-in plan price, free expedited shipping, and compounded semaglutide starting at $139 first month with 12-week renewals noted in the source.
- Choose Regenics if you prefer nurse-practitioner-led compounded GLP-1 care with a Sermorelin peptide option and promotional first-month pricing of semaglutide $139 or tirzepatide $189, with renewals captured at $199 and $279 respectively.